MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to ...

The Nuance Audio smart glasses designed to help those with hearing loss have gained FDA approval, meaning they can be explicitly sold OTC in the US for that purpose. The EssilorLuxottica brand’s ...

On its fourth attempt to pass muster with the FDA, the company’s SPN-830, now branded as Onapgo, finally earned the agency’s stamp of approval to treat motor fluctuations in adults with ...

Vertex just won approval for a drug to treat one of ... according to a Society of Actuaries report. First, a bit of background on the pain-drug environment in the U.S. so far.

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults. The active ingredient in Journavx is suzetrigine ...

EssilorLuxottica, the holding company behind eyewear brands like Ray-Ban, Oakley, and Foster Grant, showcased its latest innovation at CES 2025--the Nuance Audio hearing glasses. These glasses ...

J.M. Smucker, which owns Hostess, said that titanium dioxide is a common ingredient approved by the FDA and that its products follow the FDA regulations that the quantity of titanium not exceed 1% ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

FDA Approves First New Non-Opioid Pain Pill in Decades By India Edwards HealthDay Reporter FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved ...